Many cancer biomarkers have been elucidated, such as KRAS in colorectal cancer (Dienstmann et al., 2015), human epidermal factor receptor 2(HER2) in breast cancer (Harbeck and Gnant, 2017), and EGFR in lung cancer (Paez et al., 2004). This evidence concerns the gene ERBB2 and lung carcinoma.